D. E. Shaw & Co., Inc. Omeros Corp Transaction History
D. E. Shaw & Co., Inc.
- $125 Billion
- Q2 2025
A detailed history of D. E. Shaw & Co., Inc. transactions in Omeros Corp stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 1,647,426 shares of OMER stock, worth $6.89 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,647,426
Previous 1,938,528
15.02%
Holding current value
$6.89 Million
Previous $15.9 Million
68.98%
% of portfolio
0.0%
Previous 0.02%
Shares
32 transactions
Others Institutions Holding OMER
# of Institutions
139Shares Held
29.7MCall Options Held
383KPut Options Held
1.22M-
Black Rock Inc. New York, NY4.1MShares$17.1 Million0.0% of portfolio
-
Ingalls & Snyder LLC New York, NY3.98MShares$16.6 Million0.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.28MShares$13.7 Million0.0% of portfolio
-
Stifel Financial Corp St. Louis, MO1.52MShares$6.37 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.37MShares$5.73 Million0.0% of portfolio
About OMEROS CORP
- Ticker OMER
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,730,000
- Market Cap $262M
- Description
- Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...